本文翻译正在准备中。在此之前，我们暂时显示英文原文。
商业 · 2022/1/31 分钟阅读
Prospective Grant of an Exclusive Patent License: A Diagnostic Tool Based Upon Magnetic Resonance Spectroscopy Pre-Processing and Renormalization
本地自动翻译 · 来源原始语言
摘要
The Food and Drug Administration (FDA) is contemplating the grant of an Exclusive Patent License to practice the invention embodied in the U.S. Patent listed in the SUPPLEMENTARY INFORMATION section of this notice to Voxel Systems, LLC located in Houston, Texas.
来源原始语言: Federal Register — Food and Drug Administration打开原始公告 →